Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Non-cash Items: 2021-2022

Historic Non-cash Items for Immuneering (IMRX) over the last 2 years, with Dec 2022 value amounting to $2.7 million.

  • Immuneering's Non-cash Items fell 90.17% to $2.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $2.7 million, marking a year-over-year decrease of 90.17%. This contributed to the annual value of $2.7 million for FY2022, which is 90.17% down from last year.
  • Per Immuneering's latest filing, its Non-cash Items stood at $2.7 million for FY2022, which was down 90.17% from $27.6 million recorded in FY2021.
  • Immuneering's 5-year Non-cash Items high stood at $27.6 million for FY2021, and its period low was $2.7 million during FY2022.
  • Its 2-year average for Non-cash Items is $15.2 million, with a median of $15.2 million in 2021.
  • Data for Immuneering's Non-cash Items shows a maximum YoY slumped of 90.17% (in 2022) over the last 5 years.
  • Yearly analysis of 2 years shows Immuneering's Non-cash Items stood at $27.6 million in 2021, then plummeted by 90.17% to $2.7 million in 2022.